+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Benazepril"

ACE Inhibitors Market Report 2025 - Product Thumbnail Image

ACE Inhibitors Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Anti-Hypertensive Drugs Market Report 2025 - Product Thumbnail Image

Anti-Hypertensive Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
From
Investigation Report on China's Metoprolol Market, 2018-2022 - Product Thumbnail Image

Investigation Report on China's Metoprolol Market, 2018-2022

  • Report
  • November 2018
  • 30 Pages
  • China
From
From
Hypertension Drugs Markets in China - Product Thumbnail Image

Hypertension Drugs Markets in China

  • Report
  • March 2025
  • 215 Pages
  • China
From
Hypertension Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Hypertension Drugs Industry Forecasts - China Focus

  • Report
  • March 2025
  • 109 Pages
  • China
From
  • 8 Results (Page 1 of 1)
Loading Indicator

Benazepril is a cardiovascular drug used to treat high blood pressure and congestive heart failure. It is an angiotensin-converting enzyme (ACE) inhibitor, which works by blocking the production of a hormone that causes blood vessels to narrow. This helps to relax the blood vessels and reduce blood pressure. Benazepril is also used to reduce the risk of stroke in people with high blood pressure and an enlarged heart. Benazepril is available in both generic and brand-name forms. It is typically taken once or twice daily, with or without food. Common side effects include dizziness, headache, and fatigue. The benazepril market is highly competitive, with a number of generic and brand-name drugs available. Companies such as Pfizer, Novartis, and Merck & Co. are among the major players in the market. Other companies include Mylan, Teva Pharmaceuticals, and Sandoz. Show Less Read more